Call us now0755-8668-0658 E-mailinfo@immuclin.com

08

04

Ishikoning obtained AAA credit rating enterprise certification
Article Author:admin Category:Coperate News Reading:378
Recently, Shenzhen Yishi Kangning Biotechnology Co., Ltd. has obtained the enterprise credit rating "AAA" certificate issued by Beijing Guofutai Credit Management Co., Ltd., a credit service agency in the business field recommended by the State-owned Assets Supervision and Administration Commission of the Ministry of Commerce. In this corporate credit rating, ISKCON was awarded the “AAA” corporate credit rating for its excellent quality management, stable financial status, outstanding operating performance and excellent corporate credit, which fully demonstrates that ISKCON has a good reputation both inside and outside the industry. The credibility of the company is a well-known brand worthy of the trust of our customers.
ISKCON AAA Enterprise Credit Rating Certificate

Enterprise credit rating certification is an activity that is authorized by the Ministry of Commerce and the State-owned Assets Supervision and Administration Commission of the State Council for credit management agencies to evaluate the business credit capacity of small and medium-sized enterprises across the country and the comprehensive health status of business operations. Strictly evaluate the company’s ability to develop business credit and the comprehensive health of the company’s business operations, and finally the Ministry of Commerce and the State-owned Assets Supervision and Administration Commission of the State Council will issue a unified credit rating evaluation number and card, and give the Ministry of Commerce website publicity and record. "AAA" is the highest level of credit rating and is a high recognition of ISKCON's credit construction.

After four years of development and precipitation, Ishikoning has developed into the most competitive targeted anti-tumor immunotherapy technology leader in China, and has established a good reputation both in quality management, technical support services and credibility both inside and outside the industry . Ishikoning will continue to work hard and continuously improve, to provide customers with more cutting-edge technology, better products and better services, and continue to lead and promote the development of anti-tumor immunotherapy in China.

Keyword:
Share: